Lecture 5 Flashcards

1
Q

Obstruction of airway flow in asthma is due to 3 things

A

airway inflammation
bronchial hyperresponsiveness
smooth muscle constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Asthma is

A

chronic long term inflammatory condition affecting the upper airways in the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

asthma is characterized by

A

reversible bronchoconstriction and SOB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

COPD is

A

a chronic progressive respiratory disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

COPD causes

A

irreversible restricted airflow and breathing problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

restricted airflow is due to

A

destruction of parts of the lung including alveoli.
mucus blocking the airways
inflammation and swelling of the airway lining.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

is COPD curable?

A

Not curable, but can be managed by medications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

benefits of inhaled drug deposition

A
  • effective use of smaller dose
  • lower incidence of unwanted systemic effects
  • rapid onset of action
  • controlled delivery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name two common short acting beta agonists

A

salbutamol and terbutaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

name two common LABA

A

sameterol, formoterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MOA of B2 agonists

A
  1. B2 agonists bind and stabilize the receptor in the activated stage.
  2. activates adenylate cyclase, increases generation of cAMP from ATP
  3. cAMP inhibits Ca, hyperpolarizes smooth muscle cells = bronchodilation
  4. cAMP also activates protein kinase A, incrasing protein phosphorylation, regulates smooth muscle tone, = bronchodilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what happens with frequent use of B2 agonists

A
  1. enhance inflammatory pathways, downregulation of B2receptors and tolerance to bronchodilator effects
  2. receptors desensitize rapidly, so B2 agonists do not reduce airway inflammation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SABA onset of action

A

5 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SABA peak effect (max bronchodilation)

A

15-30 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how long do SABA bronchodilation effect last until

A

2-6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How are SABAs administered

A

Inhalation, salbutamol sometimes given with IV infusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When should SABAs be used and why

A

intermittently or as needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

LABA duration of action

A

up to 12 hours, more lipophilic than SABAs and bind to the lipid of the smooth muscle cell membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which LABA has slower onset compared to others

A

salmeterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

low efficacy agonist LABA

A

salmeterol (60% partial agonist activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

high efficacy agonists LABA

A

formoterol and Indacaterol - full agonist activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

should LABAs be used alone in asthma

A

NO! should be used as an add on to ICS to control persistent symptoms in adults. It reduces the risk of exacerbations compared to ICS alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

should LABAs be used alone in COPD

A

Can be used alone or in combo with CIS or LAMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what do LABAs do alone in COPD

A

improve symptoms and exercise tolerance by reducing both air trapping and exacerbations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

ADRs of B2 agonists

A

muscle tremors, restlessness, headache, arrythmias and tachycardia. Hypokalemia in high doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

LABAS AND SABAS should be used with

A

Inhaled Corticosteroids for anti-inflammatory therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

2 steps of Glucocorticoid receptors

A
  1. bind GS and GR undergoes confirmational change, ebcomes activates and dissociates from multi-protein complexes
  2. GR transolcates into the nucleus and regulates gene expression.
28
Q

Which enzyme moves a gene to the active stage

A

histone acetyltransferases

29
Q

which enzyme silences the genes

A

histone deacetylases

30
Q

what genes do GCS turn on/off

A

Switch ON anti-inflammatory gene expression
Switch OFF inflammatory gene expression

31
Q

Do CS have any benefit in the initial stages

A

NO, not in an acute attack bc they are NOT bronchodilators just anti-inflammatory agents.

32
Q

what do CS enable in asthma

A

less frequent use of bronchodilators

33
Q

List 4 common systemic corticosteroids

A

prednisone, prednisolone, methylprednisolone, hydrocortisone

34
Q

Name 6 inhaled corticosteroids

A

Beclomethasone, budenoside ciclesonide, fluticasone, mometasone, triamcinolone

35
Q

When should ICS be used for asthma

A

drug of choice for regular controller therapy, should be used regularly

36
Q

side effects local of ICS

A

hoarseness (dysphonia) caused by drug deposition on vocal cords
throat irritation
coughing
thrush

37
Q

ICS prolonged use SE

A

increased pneumonia risk
cataracs
HPA axis supression
osteoporosis
growth restriction
skin thinning/bruising

38
Q

benefits of LABA ICS therapy

A

adding a laba to an ICS is more effective than doubling ICS dose which also limits risk of side effects.

39
Q

what does the M3 receptor in the airways do

A

bronchoconstriction, increased bronchial secretions

40
Q

name a SAMA

A

ipratropium

41
Q

name a LAMA

A

Tiotroprium

42
Q

SAMA onset of action, peak, duration of action

A

15 mins, peak at 1-2 hours, duration of action 5-6 hours

43
Q

Ipratropium SE

A

metallic/bitter taste when inhaled

44
Q

LAMA MOA

A

functionally selective for M3 receptors due to faster disassociation from M2

45
Q

Onset, peak, duration of action

A

30 mins, 3-4 hours, 24 hours

46
Q

what is the dosing of a LAMA

A

once daily dosing

47
Q

SE LAMA

A

dry mouth, tachycardia, urinary retentoin

48
Q

why is tiotropium better than ipratropium?

A

more specific, longer duration of efficacy

49
Q

are antimuscarinics more or less effective as bronchodilators than b2 agonists

A

less

50
Q

role of antimuscarinics in COPD

A

release of ACh causes vagally-mediated bronchospasm, major reversible component of COPD

51
Q

LABA + LAMA combo therapy

A

additive bronchodilator effect, not synergistic

52
Q

PDE’s roles

A

hydrolyze cAMP and cGMP, hence they deactivate their cAMP/cGMP mediated effects

53
Q

which PDE is important for anti-inflammatory stuff

A

PDE 4

54
Q

methylxanthines are ?

A

PDE inhibitors

55
Q

Methylxanthines act to relax airways by

A

inhibit PDEs
Antagonize Adenosine receptors
activation of histone deacetylases

56
Q

how do methylxanthines work on adenosine recepors

A

adenosine causes bronchocontriction and inflammation. Methylxanthines inhibit the receptors thus causing bronchodilation and anti-inflammatory effects

57
Q

name two methylxanthines

A

theophylline and aminophylline

58
Q

PDE4 inhibitor

A

roflumilast

59
Q

Indication of Roflumilast

A

Patients with COPD with chronic bronchitis , with frequent exacerbations

60
Q

can roflumilast be used alone

A

NO! only has anti-inflammatory effects, doenst work for relief of acute symptoms.

61
Q

what is Roflumilast CI in

A

patients taking theophylline because it reduces roflumilast clearance

62
Q

Leukotrienes are a family of ______

A

inflammatory lipid mediators

63
Q

leukotrienes cause

A

narrowing and swelling of the airways in the lungs

64
Q

name two leukotriene receptor antagonists

A

Montelukast and Zafirlukast

65
Q
A